List view / Grid view

Committee for Medicinal Products for Human Use (CHMP)

 

news

CHMP issues positive opinion for Tagrisso (osimertinib)

18 December 2015 | By Victoria White

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing authorisation of AstraZeneca’s Tagrisso (AZD9291, osimertinib) 80mg once-daily tablets for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small…

news

CHMP recommends heart failure drug Entresto

25 September 2015 | By Victoria White

The CHMP has adopted a positive opinion for Novartis’ Entresto (sacubitril/valsartan), marking an important milestone towards the drug becoming available in the EU.